ABABIL Healthcare offers an extensive line of critical care products such as patient monitors to assist in decision-making while improving patient safety and hospital efficiency, a wide range of products for use in diagnostic cardiology embracing ambulatory blood pressure and ECG monitoring plus ECG data management, and a highly respected family of anesthesia system and Infusion pumps.
In addition, Mortara is committed to diagnostic electrocardiography. This commitment is embodied in its innovative portfolio of diagnostic ECG devices designed to serve the continuum of clinical care. Spanning remote ECG acquisition in telemedicine applications, to physician office and hospital solutions and beyond to the unique requirements of clinical trials, Mortara has the right device to meet today’s challenges.
Today Mortara is defining the horizon by enabling low cost, wireless solutions with its go wireless technology platform; encouraging open architecture IT solutions with its embrace of DICOM; and opening up new possibilities with fully featured mobile ECG devices such as the ELI 10electrocardiograph. Clinical Trials Services group, well-known for its focus on cardiac safety research, is assisting in clinical trials in more than 60 countries worldwide.
Ask your ECG provider the question: Do you support DICOM for Diagnostic ECG?
DICOM for Diagnostic ECG is the standards based approach for integration of diagnostic ECG waveform into the hospital enterprise. The standard supports full fidelity 12-lead ECG data, complete bi-directional modality integration, and multiple diagnostic cardiology modalities.
Choosing DICOM provides a complete standards-based solution ranging from modality work lists at the electrocardiograph, stress exercise or Holter system, to storage in PACS or CIS platforms with reporting and visualization of results within DICOM workstations. All this with no proprietary system requirements that complicate hospital interfaces and compromise your freedom of choice.
The go wireless platform is comprised of proprietary Mortara technology that is specifically designed to offer an equivalent or lower cost alternative to wired designs in ECG applications. The go wireless technology is optimized for diagnostic ECG acquisition with simple configuration, long battery life, and robust transmission protocols to be integrated into a wide array of ECG acquisition product.
Masimo - What's the Difference?
What makes Masimo SET different than other (conventional) pulse oximetry?
Conventional pulse oximetry assumes that arterial blood is the only blood moving (pulsating) in the measurement site. During patient motion, the venous blood also moves, which causes conventional pulse oximetry to under-read because it cannot distinguish between the arterial and venous blood. Masimo SET signal processing identifies the venous blood signal, isolates it, and using adaptive filters, cancels the noise and extracts the arterial signal. It then reports the true arterial oxygen saturation and pulse rate.
Conventional Pulse Oximetry provides inaccurate monitoring or signal dropout during:
- Patient Motion or Movement
- Low Perfusion (low signal amplitude)
- Intense Ambient Light (lighting or sunlight)
- Electrosurgical Instrument Interference
Masimo SET pulse oximetry works accurately where conventional pulse oximetry tends to fail. More than 100 independent and objective peer-reviewed clinical studies published and presented in internationally respected forums and numerous additional studies in progress document the significantly superior performance of Masimo SET Pulse Oximetry. The technical innovations that are the basis of the Masimo SET Pulse Oximetry system and Masimo LNOP® SpO2 sensors are addressed by approximately 200 patents issued and pending in the United States and other key countries.
Masimo SET uses Adaptive Filters DST, SST, FST and MST, in parallel processing mode (all patented by Masimo). Masimo SET's four unique algorithms, along with conventional red over infrared algorithm allows for unprecedented fidelity, sensitivity and specificity. Patient data is presented to the set of algorithms. Each algorithm's unique strengths are leveraged to ensure accurate readings through all patient conditions.
Masimo SET’s most powerful algorithm is DST. All algorithms depend upon assumptions. The more assumptions, the weaker the algorithm. DST makes only one assumption—that arterial blood has a higher oxygenation than venous—making it the most powerful pulse oximetry algorithm.
Independent clinical studies show Masimo SET is the leading SpO2 technology. It outperforms other pulse oximeters on patients with motion or movement, patients with low perfusion and under difficult conditions.
|This study measured the occurrence rate of missed true events during 40 low blood-oxygen episodes and false alarms during 120 fully oxygenated episodes, both during conditions of motion.|
|This study measured missed true desaturation events out of 75 true events on 5 children undergoing evaluation for sleep-disordered breathing.|
|This study measured missed true events and false alarms over a 28 hour period, comparing Masimo SET to other “motion- resistant” pulse oximetry technologies.|